 lupron retard prolifer ovarian epitheli tumor cell serum-fre medium patient recurr ovarian epitheli cancer respond treatment gnrh agonist effect suppress pituitari gonadotropin releas present vitro studi effect human gonadotropin pergon lh/fsh lupron gnrh agonist prolifer ovarian cancer cell line estrogen receptor neg serum-fre defin medium pergon iu/ml iu/ml cell prolifer stabil ovarian tumor vivo due decreas serum gonadotropin lupron micrograms/ml micrograms/ml cell divis day cultur dose-depend manner flow cytometr cell cycl phase dna analysi lupron revers increas portion cell rest phase control log growth correspond decreas portion cell dna synthesi phase long-term cultur week lupron cell experiment cultur cell number similar cultur lupron effect ovarian cancer cell prolifer independ gonadotropin steroid cell cycl regulatori event durat benefit vivo patient total tumor volum time treatment